Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma

- Mercieca-Bebber, R., Barnes, E. H., Leung, J., Wang, T., Bohmer, R., Cameron, D., Simes, J., Gebski, V., Smithers, M., Thomas, J., Zalcberg, J., Barbour, A. P., Wilson, K., Samoon, Z., Walpole, E., Mai, T., Ackland, S., Burge, M., Dickie, G., Watson, D.

Lessons learned from a pilot study of an Indigenous patient navigator intervention in Queensland, Australia

- Bernardes, C. M., Martin, J., Cole, P., Kitchener, T., Cowburn, G., Garvey, G., Walpole, E., Valery, P. C.

Follow-up cancer care: perspectives of Aboriginal and Torres Strait Islander cancer survivors

- Meiklejohn, J. A., Garvey, G., Valery, P. C., Bailie, R., Walpole, E., Adams, J., Williamson, D., Martin, J., Bernardes, C. M., Arley, B., Marcusson, B.

Relapse patterns after chemo-radiation for carcinoma of the oesophagus

- Denham, J. W., Steigler, A., Smithers, B. M., Ackland, S., Walpole, E., Kilmurray, J., Wratten, C., Burmeister, B., Lam, D. S., Joseph, D., Delaney, G., Christie, D., Jamieson, G.